Last reviewed · How we verify
Mydriacyl Ophthalmic Product
Mydriacyl Ophthalmic Product is a Small molecule drug developed by Mantis Photonics AB. It is currently in Phase 1 development.
At a glance
| Generic name | Mydriacyl Ophthalmic Product |
|---|---|
| Sponsor | Mantis Photonics AB |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.
- Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.
- Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa (NA)
- Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution (PHASE1, PHASE2)
- Evaluation of Pupil Dilation Speed With the MAP Dispenser (PHASE4)
- Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients (PHASE4)
- Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
- The Effect of Brimonidine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mydriacyl Ophthalmic Product CI brief — competitive landscape report
- Mydriacyl Ophthalmic Product updates RSS · CI watch RSS
- Mantis Photonics AB portfolio CI
Frequently asked questions about Mydriacyl Ophthalmic Product
What is Mydriacyl Ophthalmic Product?
Mydriacyl Ophthalmic Product is a Small molecule drug developed by Mantis Photonics AB.
Who makes Mydriacyl Ophthalmic Product?
Mydriacyl Ophthalmic Product is developed by Mantis Photonics AB (see full Mantis Photonics AB pipeline at /company/mantis-photonics-ab).
What development phase is Mydriacyl Ophthalmic Product in?
Mydriacyl Ophthalmic Product is in Phase 1.
Related
- Manufacturer: Mantis Photonics AB — full pipeline